4//SEC Filing
Collins James J. 4
Accession 0001104659-19-040972
CIK 0001680581other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:28 PM ET
Size
5.3 KB
Accession
0001104659-19-040972
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (right to buy)
2019-07-18+5,714→ 5,714 totalExercise: $16.00Exp: 2029-07-17→ Common Stock (5,714 underlying)
Footnotes (1)
- [F1]The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest on July 18, 2020 or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001779269
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 5:28 PM ET
- Size
- 5.3 KB